TSLA
Tesla
-- 379.280 NVDA
NVIDIA
-- 138.310 RGTI
Rigetti Computing
-- 20.0000 PLTR
Palantir
-- 75.190 AMD
Advanced Micro Devices
-- 120.630 
News
$Verastem (VSTM.US)$ Reuters· 4 mins ago
Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination With Defactinib for the Treatment of Recurrent Kras Mutant Low-Grade Serous Ovarian Cancer! Pdufa Target Action Date Set for June 30, 2025
Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination With Defactinib for the Treatment of Recurrent Kras Mutant Low-Grade Serous Ovarian Cancer! Pdufa Target Action Date Set for June 30, 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment